| 1 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
Those specific markers are used to detect dopaminerfic neurons. Which are target cells that can be used to treat Parkinson’s disease. |
Based on stemPD -reclined study |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
AI is used to help doctors read scans for more accuracy or a second opinion on the matter. This makes the process faster and helps detect any diseases quicker improving quick recovery for the patient. |
Scoping review on AI acceptability in medical imagining it talks about rather than replacing healthcare professionals AI is used to kind of monitor and assist heslthcare professionals when looking at scans. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
It helps doctors analyze the scans and giving assistance or an extra opinion on the matter. So when a difficult case comes by AI can help solidify their decision and make more accurate ones. |
The scoping review of AI acceptability in medical imaging
Talks about how Ai can be a decision making tool |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
|
Scoping review on AI acceptance in medical imaging |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of the AI machine has no correlation to influencing the acceptability of it to healthcare professionals as it doesn’t change their opinions just because it’s a color they like it depends on the performance, what it’s used for and the overall feedback from others. |
Scoping review on AI acceptance in medical imaging |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
People see AI as a way of cheating in the healthcare world and is highly controversial to use. |
Scoping review on AI acceptance in medical imaging |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
A major concern about the rapid usage of AI for every line of work is the fear that it will take their jobs, this creates the fear that there will be no need for certain professional's. |
Scoping review on AI acceptance in medical imaging
Mentiones fear of job displacement, and Ai replacing professionals. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Healthcare professionals evaluate either to use Ai by their own personal values for them and their patience, if it seems to go against it they are unlikely to use it. |
Ai acceptability in medical imaging where they mention the ethics of using Ai in a key factor when it comes to using it. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson’s disease is caused when the dopamine neurons in the brain dies and makes movement difficult so embryonic cells can help with that by replacing the dopamine neurons in the brain and making the brain work more "normally" and improve movement. |
StemPD preclinical study it talks about using embryonic cells to replace dopamine neurons to improve movement in patients with Parkinson’s disease. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
They tested on rats to make sure the experiment was safe and if it actually worked by improving movement. |
StemPD preclinical study, mentiones how they used rats as models to test if the experiment would work and would help patience recover. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
6 months |
|
It lasted 6 months, to make sure that the experiment was safe and if it truly worked or had any long term side effects to the rat. |
StemPD preclinical study, they took 6 months for the stem cells to settle in to make sure the results were safe and had no long term side effects on the rats. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
The studies mentioned phase I/IIa clinical trial, it was an early human trial that checks safety and signs of improvement. |
StemPD preclinical study talking about how the phase II/Ia was use to evaluate dosing amount, safety, and effects before larger sale trials can take place. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
They follow strict rules and regulations while creating the product to ensure cell safety. |
StemPD preclinical study it states that the products are made under the GMP rules to ensure its up to global standards . |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
The study confirmed that the rats did not gain any tumors or any negative reactions declaring that the test was safe |
StemPD preclinical study talks about the safety evaluation needed to be done on the animals to declare that th tests was truly safe enough to be performed on real patience by analyzing and seeing if there’s any long term effects once there is non it can be declared as safe. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
After the rats underwent the transplant the symptoms of the Parkinson’s disease started to decrease allow more motor movements in the rat |
StemPD preclinical efficacy studies talks about how success will be measured in this experiment. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
The main goal of the stemPD treatment was to improve movement. So after an experiment they would measure of the rat had more movement. |
StemPD preclined study for Parkinson’s disease. The study talks about due to the lost of dopamine neurons movement is limited therefore the main goal is to recover movement. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|